Growth Metrics

Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020)

Tarsus Pharmaceuticals (TARS) has 1 years of Other Accumulated Expenses data on record, last reported at $447000.0 in Q3 2020.